Literature DB >> 26725091

Association of seizure duration and outcome in refractory status epilepticus.

Dominik Madžar1, Anna Geyer2, Ruben U Knappe2, Stephanie Gollwitzer2, Joji B Kuramatsu2, Stefan T Gerner2, Hajo M Hamer2, Hagen B Huttner2.   

Abstract

The aim of the study was to identify factors influencing long-term outcome and to evaluate the prognostic power of the Status Epilepticus Severity Score (STESS) in refractory status epilepticus (RSE). We retrospectively extracted data on baseline characteristics, RSE details, and hospital course including complications from all patients treated for RSE in our institution between January 2001 and January 2013. Functional outcome was assessed using the modified Rankin Scale (mRS) and was defined as good when either RSE did not lead to functional decline or when the resulting mRS score was 2 or below. Seventy-one episodes in 65 patients were analyzed. The median follow-up time was 12 weeks (IQR 6-35), two patients were lost to follow-up. Poor functional long-term outcome was observed in 42/69 (60.9%) episodes. In-hospital mortality occurred in 13/71 (18.3%) episodes. Multivariable analysis revealed that STESS ≥ 3, longer RSE duration, and sepsis were independently related to poor functional long-term outcome. Receiver operating characteristics (ROC) curve analyses confirmed the cut-off dichotomization into STESS ≥ 3 and STESS < 3 for optimal discrimination between good and poor outcome (AUC = 0.671, p = 0.002, YI = 0.368, NPV = 0.607, PPV = 0.756) and revealed an RSE duration of 10 days as a significant cut-off point associated with outcome (AUC = 0.712, p = 0.012, YI = 0.310; NPV = 0.545, PPV = 0.750). In conclusion, STESS and RSE duration represent relevant scores and parameters impacting long-term outcome after RSE. A shorter RSE duration is associated with better outcome and, therefore, rapid and adequate treatment for seizure termination should be enforced.

Entities:  

Keywords:  Outcome; Refractory status epilepticus; Seizure duration; Status Epilepticus Severity Score

Mesh:

Year:  2016        PMID: 26725091     DOI: 10.1007/s00415-015-7992-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  33 in total

1.  Cerebral vascular accidents in patients over the age of 60. II. Prognosis.

Authors:  J RANKIN
Journal:  Scott Med J       Date:  1957-05       Impact factor: 0.729

Review 2.  The management of refractory status epilepticus: an update.

Authors:  Daniel H Lowenstein
Journal:  Epilepsia       Date:  2006       Impact factor: 5.864

3.  Refractory status epilepticus: frequency, risk factors, and impact on outcome.

Authors:  Stephan A Mayer; Jan Claassen; Johnny Lokin; Felicia Mendelsohn; Lyle J Dennis; Brian-Fred Fitzsimmons
Journal:  Arch Neurol       Date:  2002-02

4.  Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study.

Authors:  Raoul Sutter; Stephan Marsch; Peter Fuhr; Stephan Rüegg
Journal:  Epilepsia       Date:  2013-01-07       Impact factor: 5.864

Review 5.  Treatment strategies for refractory status epilepticus.

Authors:  Martin Holtkamp
Journal:  Curr Opin Crit Care       Date:  2011-04       Impact factor: 3.687

6.  A clinical score for prognosis of status epilepticus in adults.

Authors:  Andrea O Rossetti; Giancarlo Logroscino; Edward B Bromfield
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

7.  Functional and cognitive outcome in prolonged refractory status epilepticus.

Authors:  Alex D Cooper; Jeffrey W Britton; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2009-12

8.  Independent external validation of the status epilepticus severity score.

Authors:  Raoul Sutter; Peter W Kaplan; Stephan Rüegg
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

9.  Early predictors of refractory status epilepticus: an international two-center study.

Authors:  R Sutter; P W Kaplan; S Marsch; E M Hammel; S Rüegg; W C Ziai
Journal:  Eur J Neurol       Date:  2014-08-07       Impact factor: 6.089

10.  Functional outcome of prolonged refractory status epilepticus.

Authors:  Alexandre Lai; Hervé D Outin; Julien Jabot; Bruno Mégarbane; Stéphane Gaudry; Rémi Coudroy; Guillaume Louis; Francis Schneider; Nicolas Barbarot; Antoine Roch; Nicolas Lerolle; David Luis; François Fourrier; Anne Renault; Laurent Argaud; Tarek Sharshar; Sébastien Gibot; Pierre-Edouard Bollaert
Journal:  Crit Care       Date:  2015-04-30       Impact factor: 9.097

View more
  15 in total

1.  Association of Time to Treatment With Short-term Outcomes for Pediatric Patients With Refractory Convulsive Status Epilepticus.

Authors:  Marina Gaínza-Lein; Iván Sánchez Fernández; Michele Jackson; Nicholas S Abend; Ravindra Arya; J Nicholas Brenton; Jessica L Carpenter; Kevin E Chapman; William D Gaillard; Tracy A Glauser; Joshua L Goldstein; Howard P Goodkin; Kush Kapur; Mohamad A Mikati; Katrina Peariso; Robert C Tasker; Dmitry Tchapyjnikov; Alexis A Topjian; Mark S Wainwright; Angus Wilfong; Korwyn Williams; Tobias Loddenkemper
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

Review 2.  Timing is everything: Where status epilepticus treatment fails.

Authors:  Chloe E Hill; Alomi O Parikh; Colin Ellis; Jennifer S Myers; Brian Litt
Journal:  Ann Neurol       Date:  2017-07-29       Impact factor: 10.422

3.  Acute Resective Surgery for the Treatment of Refractory Status Epilepticus.

Authors:  Maysaa Merhi Basha; Kushak Suchdev; Monica Dhakar; William J Kupsky; Sandeep Mittal; Aashit K Shah
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

4.  Clinico-biological markers for the prognosis of status epilepticus in adults.

Authors:  Aurélie Hanin; Sophie Demeret; Virginie Lambrecq; Benjamin Rohaut; Clémence Marois; Meriem Bouguerra; Alexandre Demoule; Jean-Louis Beaudeux; Randa Bittar; Jérôme Alexandre Denis; Françoise Imbert-Bismut; Foudil Lamari; Benoit Rucheton; Dominique Bonnefont-Rousselot; Mario Chavez; Vincent Navarro
Journal:  J Neurol       Date:  2022-06-29       Impact factor: 6.682

5.  Status epilepticus alert reduces time to administration of second-line antiseizure medications.

Authors:  Mauricio F Villamar; Aaron M Cook; Chenlu Ke; Yan Xu; Jordan L Clay; Katelyn S Dolbec; Rachel Ward-Mitchell; Larry B Goldstein; Meriem Bensalem-Owen
Journal:  Neurol Clin Pract       Date:  2018-12

6.  Study of Refractory Status Epilepticus from a Tertiary Care Center.

Authors:  Sahil Kohli; Suresh Babu Pasangulapati; Sangeetha Yoganathan; Gideon Lyngsyun Rynjah; A T Prabhakar; Sanjith Aaron; Mathew Alexander; Vivek Mathew
Journal:  Ann Indian Acad Neurol       Date:  2017 Apr-Jun       Impact factor: 1.383

7.  Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study.

Authors:  Anne-Mari Kantanen; Reetta Kälviäinen; Ilkka Parviainen; Marika Ala-Peijari; Tom Bäcklund; Juha Koskenkari; Ruut Laitio; Matti Reinikainen
Journal:  Crit Care       Date:  2017-03-23       Impact factor: 9.097

Review 8.  Updates in Refractory Status Epilepticus.

Authors:  Rohit Marawar; Maysaa Basha; Advait Mahulikar; Aaron Desai; Kushak Suchdev; Aashit Shah
Journal:  Crit Care Res Pract       Date:  2018-05-08

9.  Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial.

Authors:  Abhishek G Sathe; Ellen Underwood; Lisa D Coles; Jordan J Elm; Robert Silbergleit; James M Chamberlain; Jaideep Kapur; Hannah R Cock; Nathan B Fountain; Shlomo Shinnar; Daniel H Lowenstein; Eric S Rosenthal; Robin A Conwit; Thomas P Bleck; James C Cloyd
Journal:  Epilepsia       Date:  2021-02-10       Impact factor: 5.864

Review 10.  Markers in Status Epilepticus Prognosis.

Authors:  Ayham Alkhachroum; Caroline A Der-Nigoghossian; Clio Rubinos; Jan Claassen
Journal:  J Clin Neurophysiol       Date:  2020-09       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.